Interferon- and ribavirin- free treatment using sofusbuvir, ledipasvir and a third direct acting drug for as little as six weeks can cure most previously untreated people with genotype 1 hepatitis C virus (HCV), including those with traditional predictors of poor response.

28 Mar 2014

Shorter treatment is possible for hard-to-treat patients

Simeprevir – new HCV protease inhibitor

AbbVie '3D' combination highly potent treatment for genotype 1b infection

European policy

 Screen Shot 2014-03-28 At 08.10.41

Read more here

Share this on: